RNS Hotlist with Zak Mir: HAYD, IDP, CGO, EQLS, CLIN, CYAN, PXC, IGE, HEMO, PYX & GWMO via Vox Markets

Haydale (HAYD), the advanced materials group, has been awarded a SMARTCymru grant from The Welsh Government that will enable the Ammanford-based company to progress with the development of its anti-counterfeiting ink technology, PATit. The Project has a total cost of £169,000 and is expected to take six months to complete. The SMARTCymru grant, will cover circa 50% of the anticipated project costs.

By Zak Mir

Panthera Resources (PAT), the diversified gold exploration and development company said that assay results from the 2,430 metre air-core drilling programme completed in December 2021 have now been received and assessed. The company said extensive historic gold mineralisation has been identified by previous explorers at the Kalaka Project, with drill intercepts of 249.3m @ 0.54g/t Au from 52m (to end of hole) including 8m @ 3.17g/t Au from 107m at the K1A prospect.

InnovaDerma (IDP), a UK beauty brand developer, provided a trading update for the six months ended 31 December 2021. The company said its strategy of driving increased profitable sales through gross margin improvement, radical simplification of business operations, rigorous cost control and the prioritisation of our Skinny Tan brand, is working.

Contango Holdings (CGO), the London listed natural resource development company, provided an update on the £1m Convertible Loan Note announced on 3 June 2021. Following the exercise of outstanding warrants prior to their expiry on 1 November 2021 and an additional capital raise of £2.5m, which provided the necessary funds to bring the Company’s Lubu Coking Coal Project into production by the end of Q1 2022, the company no longer has sufficient headroom under the Listing Rules to issue all the shares to satisfy the conversion in full. However, the company is pleased to report that all parties have unanimously agreed to extend the life of the instruments by a further six months with no additional charges or penalties.

Equals (EQLS), the fintech payments group focused, is pleased to announce a strong trading performance for the financial year ended 31 December 2021 resulting in unaudited revenue of £44.1 million, an increase of 52% on FY-20. FY-21 ended strongly with revenue for Q4-21 at £15.3 million, up 96% on Q4-20 and up 28.1% on Q3-21. The group said it is also in a robust financial position with £13.2 million of cash at bank as at 31 December 2021.

Clinigen Group (CLIN), the global pharmaceutical Services and Products company, provides an unaudited trading update for the six months ended 31 December 2021. Clinigen reiterates guidance namely that it expects FY2022 EBITDA growth of between 5% and 10%. The group expects to see a second half weighting to the full year numbers.

CyanConnode (CYAN), the Narrowband Radio Frequency Smart Mesh Networks group, provided a trading update for the nine-month period ended 31 December 2021. Turnover hit £6.8m (2020: £3.4m), with cash at 31 December 2021 of £1.1m (2020: £1.0m). Approximately £5.9m cash received from customers (2020: £2.9m). The company said it has continued to make solid progress during the financial year with record turnover and cash collection, and expects to meet market forecasts for the current financial year.

Phoenix Copper (PXC), the AIM quoted USA focused base and precious metals emerging producer and exploration company, announced the assay results from additional drilling at the Red Star silver – lead deposit, adjacent to the Empire Mine Open Pit Project, Custer County, Idaho, USA. The company said all seven drill holes encountered mineralization consistent with, if not exceeding, the grades in the maiden Red Star resource, further demonstrating the widespread polymetallic mineralization at Empire, and the continuity of a northerly trending system. These results, and the results of the ground magnetic survey recently completed on Red Star, will be used to target a planned 3,000 m diamond core drilling programme in 2022.

Image Scan (IGE) specialists in the field of X-ray imaging for the security and industrial inspection markets, announced the market launch of the ThreatScan®-AS1 integrated portable X-Ray system for bomb squads and security professionals worldwide. Private demonstrations have already been carried out, and the system will be shown to the wider security community for the first time at the upcoming Intersec exhibition in Dubai.

Hemogenyx Pharmaceuticals (HEMO), the biopharmaceutical group, announced a further step in the development of its CDX programme. Hemogenyx Pharmaceuticals and Selexis SA, have signed a service agreement to develop the cell line for the Company’s CDX bispecific antibody for the treatment of acute myeloid leukemia. Under the agreement, Hemogenyx Pharmaceuticals will leverage Selexis’ proprietary SUREtechnology Platform™, a suite of cell line development tools and technologies that significantly reduces the time, effort, and costs associated with developing high-performance mammalian cell lines.

PYX Resources (PYX), said it has started production and sales activity of natural rutile from its Mandiri deposit in Central Kalimantan, Indonesia, as a by- product of its primary zircon production operation. The company said it has hit the ground running in 2022 having kicked off the production of rutile; which assists it in expanding the range of products.

Great Western Mining Corporation (GWMO), which is exploring and developing gold, silver and copper targets in Nevada, updated on the current status of its projects and outlines its plans for 2022. The company said it has started 2022 with net cash of €2,042,534 (£1,716,301) (unaudited) and no debt beyond payables arising in the normal course of business. This will enable it to pursue an active programme in 2022 across its large portfolio of assets in Nevada.

Read More

Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.

Linking Shareholders and Executives :Share Talk

If anyone reads this article found it useful, helpful? Then please subscribe www.share-talk.com or follow SHARE TALK on our Twitter page for future updates. Terms of Website Use All information is provided on an as-is basis. Where we allow Bloggers to publish articles on our platform please note these are not our opinions or views and we have no affiliation with the companies mentioned

Weekly Newsletter

Sign up to receive exclusive stock market content in your inbox, once a week.

We don’t spam! Read our privacy policy for more info.